New Pharmaceuticals market report from Global Markets Direct: "Sentinext Therapeutics Sdn Bhd - Product Pipeline Review - 2012"
Boston, MA -- (SBWIRE) -- 01/17/2013 -- Global Market Direct's pharmaceuticals report, "Sentinext Therapeutics Sdn Bhd - Product Pipeline Review - 2012" provides data on the Sentinext Therapeutics Sdn Bhd's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct's proprietary databases, Sentinext Therapeutics Sdn Bhd's corporate website, SEC filings, investor presentations and featured press releases, both from Sentinext Therapeutics Sdn Bhd and industry-specific third party sources, put together by Global Markets Direct's team.
- Sentinext Therapeutics Sdn Bhd - Brief Sentinext Therapeutics Sdn Bhd overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Sentinext Therapeutics Sdn Bhd human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Sentinext Therapeutics Sdn Bhd with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Sentinext Therapeutics Sdn Bhd's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
View Full Report Details and Table of Contents
Reasons to Get this Report
- Evaluate Sentinext Therapeutics Sdn Bhd's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Sentinext Therapeutics Sdn Bhd in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Sentinext Therapeutics Sdn Bhd's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Sentinext Therapeutics Sdn Bhd.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Sentinext Therapeutics Sdn Bhd and identify potential opportunities in those areas.
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Pharmaceuticals research reports at Fast Market Research
You may also be interested in these related reports:
- Cell Therapeutics, Inc. - Product Pipeline Review - 2012
- Gastrointestinal Tract Cancer - Pipeline Review, H2 2012
- Chelsea Therapeutics International Ltd. - Product Pipeline Review - 2012
- Onconova Therapeutics, Inc - Product Pipeline Review - 2012
- Celldex Therapeutics, Inc. - Product Pipeline Review - 2012
- Carcinomas - Pipeline Review, H2 2012
- Viral Infections - Pipeline Review, H2 2012
- Depression - Pipeline Review, H1 2012
- Nektar Therapeutics - Product Pipeline Review - 2012
- Astrocytoma - Pipeline Review, H1 2012